Lipoprotein (a) and cerebrovascular disease.
Kosmas CE, Bousvarou MD, Papakonstantinou EJ, Zoumi EA, Rallidis LS.
J Int Med Res. 2024 Jul;52(7):3000605241264182. doi: 10.1177/03000605241264182.
Infarction Patterns and Recurrent Adverse Cerebrovascular Events in Moyamoya Disease.
Yu SC, Yin ZH, Zeng CF, Lin F, Ma L, Zhang Y, Zhang D, Zhao JZ.
Dis Markers. 2022 Mar 29;2022:8255018. doi: 10.1155/2022/8255018. eCollection 2022.
Cerebrovascular disease in women.
Knepper LE, Giuliani MJ.
Cardiology. 1995;86(4):339-48. doi: 10.1159/000176898.
Cerebrovascular Moyamoya disease.
Yamashiro Y, Takahashi H, Takahashi K.
Eur J Pediatr. 1984 Apr;142(1):44-50. doi: 10.1007/BF00442590.
[Cerebrovascular disease in the tropics].
del Brutto OH.
Rev Neurol. 2001 Oct 16-31;33(8):750-62.
Headache in cerebrovascular disease.
Portenoy RK, Abissi CJ, Lipton RB, Berger AR, Mebler MF, Baglivo J, Solomon S.
Stroke. 1984 Nov-Dec;15(6):1009-12. doi: 10.1161/01.str.15.6.1009.
Ischemic stroke recurrence and mortality in different imaging phenotypes of ischemic cerebrovascular disease: The SMART-MR Study.
Lucci C, Rissanen I, de Jong PA, Kappelle LJ, Hendrikse J, Geerlings MI.
Eur Stroke J. 2023 Jun;8(2):522-531. doi: 10.1177/23969873231162122. Epub 2023 Mar 10.
Contributing Mechanisms of Aortic Atheroma in Ischemic Cerebrovascular Disease.
Kong Q, Ma X.
J Stroke Cerebrovasc Dis. 2015 Dec;24(12):2653-9. doi: 10.1016/j.jstrokecerebrovasdis.2015.09.033. Epub 2015 Oct 27.
Hoarseness of unclear origin may be a sign of cerebrovascular disease and herald impending recurrent brainstem stroke.
Fraser JA.
CMAJ. 2018 Sep 10;190(36):E1088. doi: 10.1503/cmaj.70005.
Cerebral microbleeds and cognition in cerebrovascular disease: an update.
Charidimou A, Werring DJ.
J Neurol Sci. 2012 Nov 15;322(1-2):50-5. doi: 10.1016/j.jns.2012.05.052. Epub 2012 Jun 18.
